EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Secondary Metabolites from Marine-Derived Bacteria with Antibiotic and Antibiofilm Activities against Drug-Resistant Pathogens

Joko Tri Wibowo iD, Asep Bayu, Widya Dwi Aryati, Carla Fernandes iD, Arry Yanuar, Anake Kijjoa iD, Masteria Yunovilsa Putra iD

Marine Drugs · 12.01.2023 · 21 (1) · 50

DOI: 10.3390/md21010050 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 12.01.2023. Verfasst von Joko Tri Wibowo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Vaccine and Drug, Research Organization for Health, National Research and Innovation Agency (BRIN), KST Soekarno Jl. Raya Bogor K…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Actinobacteria. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hibah Publikasi Terindeks Internasional (PUTI) Review Article Q1 Tahun Anggaran 2022 No-mor: NKB-741/UN2.RST/HKP.05.00/2022 and by the national funds through t…, Hibah Publikasi Terindeks Internasional (PUTI) and FCT-Foundation for Science and Technology of Portugal, Hibah Publikasi Terindeks Internasional (PUTI) Review Article Q1 Tahun Anggaran 2022.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The search for new antibiotics against drug-resistant microbes has been expanded to marine bacteria. Marine bacteria have been proven to be a prolific source of a myriad of novel compounds with potential biological activities. Therefore, this review highlights novel and bioactive compounds from marine bacteria reported during the period of January 2016 to December 2021. Published articles containing novel marine bacterial secondary metabolites that are active against drug-resistant pathogens were collected. Previously described compounds (prior to January 2016) are not included in this review. Unreported compounds during this period that exhibited activity against pathogenic microbes were discussed and compared in order to find the cue of the structure–bioactivity relationship. The results showed that Streptomyces are the most studied bacteria with undescribed bioactive compounds, followed by other genera in the Actinobacteria. We have categorized the structures of the compounds in the present review into four groups, based on their biosynthetic origins, as polyketide derivatives, amino acid derivatives, terpenoids, as well as compounds with mixed origin. These compounds were active against one or more drug-resistant pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA), methicillin-resistant Staphylococcus epidermidis (MRSE), vancomycin-resistant Enterococci (VRE), multidrug-resistant Mycobacterium tuberculosis (MDR-TB), and amphotericin B-resistant Candida albicans. In addition, some of the compounds also showed activity against biofilm formation of the test bacteria. Some previously undescribed compounds, isolated from marine-derived bacteria during this period, could have a good potential as lead compounds for the development of drug candidates to overcome multidrug-resistant pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusActinobacteriaAnti-Bacterial AgentsBacteriaBiofilmsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

drug-resistant pathogensmarine-derived bacterianovel antibioticssecondary metabolites

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Research Center for Vaccine and Drug, Research Organization for Health, National Research and Innovation Agency (BRIN), KST Soekarno Jl. Raya Bogor Km. 46, Cibinong 16911, Indonesia.
  • Faculty of Pharmacy, Universitas Indonesia, Depok 16424, Indonesia.
  • Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto and CIIMAR, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
  • National Metabolomics Collaborative Research Center, Faculty of Pharmacy, Universitas Indonesia, Kampus UI Depok, Depok 16424, Indonesia.
  • ICBAS-Instituto de Ciências Biomédicas Abel Salazar and CIIMAR, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.

ORCID-Profile: Joko Tri Wibowo, Carla Fernandes, Anake Kijjoa, Masteria Yunovilsa Putra

Förderung

  • Hibah Publikasi Terindeks Internasional (PUTI) Review Article Q1 Tahun Anggaran 2022 No-mor: NKB-741/UN2.RST/HKP.05.00/2022 and by the national funds through t…
  • Hibah Publikasi Terindeks Internasional (PUTI) and FCT-Foundation for Science and Technology of Portugal
  • Hibah Publikasi Terindeks Internasional (PUTI) Review Article Q1 Tahun Anggaran 2022
  • FCT-Foundation for Science and Technology of Portugal

Zitieren

APA

Wibowo, J. T., Bayu, A., Aryati, W. D., Fernandes, C., Yanuar, A., Kijjoa, A., & Putra, M. Y. (2023). Secondary Metabolites from Marine-Derived Bacteria with Antibiotic and Antibiofilm Activities against Drug-Resistant Pathogens. Marine Drugs, 21(1), 50. https://doi.org/10.3390/md21010050

Vancouver

Wibowo JT, Bayu A, Aryati WD, Fernandes C, Yanuar A, Kijjoa A, et al. Secondary Metabolites from Marine-Derived Bacteria with Antibiotic and Antibiofilm Activities against Drug-Resistant Pathogens. Marine Drugs. 2023;21(1):50. doi:10.3390/md21010050

BibTeX
@article{Wibowo2023,
  author = {Wibowo, Joko Tri and Bayu, Asep and Aryati, Widya Dwi and Fernandes, Carla and Yanuar, Arry and Kijjoa, Anake and Putra, Masteria Yunovilsa},
  title = {Secondary Metabolites from Marine-Derived Bacteria with Antibiotic and Antibiofilm Activities against Drug-Resistant Pathogens},
  journal = {Marine Drugs},
  year = {2023},
  volume = {21},
  number = {1},
  pages = {50},
  doi = {10.3390/md21010050}
}
Kostenlos starten →